Cutaneous Cylindromas of the Scalp and Frontal Region with Chronic Ulceration: A Case Report and Review of the Literature

Main Article Content

Mariana Carolina Zuñiga Garcia*
Luis Alberto Gonzalez Valdez
Federico Gavaldon Rios
José Manuel Santacruz Santos

Abstract

Cutaneous cylindroma is an uncommon adnexal neoplasm of presumed follicular differentiation that characteristically involves the scalp and face. It may present as a solitary sporadic lesion or, less frequently, as multiple confluent tumors in the context of CYLD cutaneous syndrome, the unifying designation for Brooke–Spiegler syndrome, familial cylindromatosis and multiple familial trichoepitheliomas. Although histologically benign, multiple scalp cylindromas produce progressive disfigurement, cicatricial alopecia, ulceration and, in a minority of patients, malignant transformation to cylindrocarcinoma, an aggressive neoplasm with documented capacity for local destruction and metastasis. We report a 64-year-old woman with a lifelong history of multiple nodular lesions of the scalp, face and trunk that began in adolescence, in whom a chronically ulcerated frontal lesion raised clinical suspicion of malignant transformation. Wide surgical excision of the frontal and scalp lesions was performed with reconstruction by a full-thickness skin graft harvested from the abdominal region. Histopathological examination demonstrated ulcerated cylindromas with free surgical margins, and graft integration reached approximately 95%. Residual scalp tumors are being managed by planned staged excision in order to preserve as much hair-bearing scalp as possible. Using this case as a framework, we review the historical background, epidemiology, histopathological features, molecular pathogenesis and contemporary management of cutaneous cylindroma, with particular emphasis on the reconstructive decisions that confront the plastic surgeon. Recognition of the clinical warning signs of malignant change, appropriate genetic characterization of the patient and family, and the principle of tissue-preserving staged surgery remain central to the modern care of these patients.

Article Details

How to Cite
Zuñiga Garcia*, M. C., Gonzalez Valdez, L. A. ., Rios, F. G. ., & Santacruz Santos, J. M. . (2026). Cutaneous Cylindromas of the Scalp and Frontal Region with Chronic Ulceration: A Case Report and Review of the Literature. International Journal of Medical Science and Clinical Research Studies, 6(09), 1896–1903. https://doi.org/10.47191/ijmscrs/v6-i9-16
Section
Articles

References

I. Jordão C, de Magalhães TC, Cuzzi T, Ramos-e-Silva M. Cylindroma: an update. Int J Dermatol. 2015;54(3):275-8.

II. Lakshmi Priya V, Johnson T, Srismitha S, Balakrishnan S. Solitary dermal cylindroma in an uncommon site: a rare case report. Cureus. 2022;14(12):e32614.

III. Nagy N, Dubois A, Szell M, Rajan N. Genetic testing in CYLD cutaneous syndrome: an update. Appl Clin Genet. 2021;14:427-44.

IV. Kim SM, Truong JL, Wu K, Gabril MY, Grant A. Malignant cylindroma of the scalp treated with staged perimeter excision: a case report and literature review. JPRAS Open. 2019;21:1-5.

V. Gerretsen AL, van der Putte SC, Deenstra W, van Vloten WA. Cutaneous cylindroma with malignant transformation. Cancer. 1993;72(5):1618-23.

VI. Lee DA, Grossman ME, Schneiderman P, Celebi JT. Genetics of skin appendage neoplasms and related syndromes. J Med Genet. 2005;42(11):811-9.

VII. Rajan N, Ashworth A. Inherited cylindromas: lessons from a rare tumour. Lancet Oncol. 2015;16(9):e460-9.

VIII. Myers DJ, Sathe NC, Fillman EP. Cylindroma. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024.

IX. Borik L, Heller P, Shrivastava M, Kazlouskaya V. Malignant cylindroma in a patient with Brooke-Spiegler syndrome. Dermatol Pract Concept. 2015;5(2):61-5.

X. Tunggal L, Ravaux J, Pesch M, Smola H, Krieg T, Gaill F, et al. Defective laminin 5 processing in cylindroma cells. Am J Pathol. 2002;160(2):459-68.

XI. Canedo T, de Almeida MP, Cuzzi T, Ramos-e-Silva M, Carneiro S. Immunophenotypic aspects of cylindroma and nodular hidradenoma. J Eur Acad Dermatol Venereol. 2010;24(2):178-85.

XII. Zheng Y, Tian Q, Wang J, Dong X, Jing H, Wang Y, et al. Differential diagnosis of eccrine spiradenoma: a case report. Exp Ther Med. 2014;8(4):1097-101.

XIII. Albores-Saavedra J, Heard SC, McLaren B, Kamino H, Witkiewicz AK. Cylindroma (dermal analog tumor) of the breast: a comparison with cylindroma of the skin and adenoid cystic carcinoma of the breast. Am J Clin Pathol. 2005;123(6):866-73.

XIV. Mahmoud A, Hill DH, O’Sullivan MJ, Bennett MW. Cylindroma of the breast: a case report and review of the literature. Diagn Pathol. 2009;4:30.

XV. Massoumi R, Podda M, Fässler R, Paus R. Cylindroma as tumor of hair follicle origin. J Invest Dermatol. 2006;126(5):1182-4.

XVI. Bignell GR, Warren W, Seal S, Takahashi M, Rapley E, Barfoot R, et al. Identification of the familial cylindromatosis tumour-suppressor gene. Nat Genet. 2000;25(2):160-5.

XVII. Brummelkamp TR, Nijman SM, Dirac AM, Bernards R. Loss of the cylindromatosis tumour suppressor inhibits apoptosis by activating NF-kappaB. Nature. 2003;424(6950):797-801.

XVIII. Corda G, Sala A. Cutaneous cylindroma: it’s all about MYB. J Pathol. 2016;239(4):391-3.

XIX. Fehr A, Kovács A, Löning T, Frierson H Jr, van den Oord J, Stenman G. The MYB-NFIB gene fusion: a novel genetic link between adenoid cystic carcinoma and dermal cylindroma. J Pathol. 2011;224(3):322-7.

XX. Rajan N, Andersson MK, Sinclair N, Fehr A, Hodgson K, Lord CJ, et al. Overexpression of MYB drives proliferation of CYLD-defective cylindroma cells. J Pathol. 2016;239(2):197-205.

XXI. Davies HR, Hodgson K, Schwalbe E, Coxhead J, Sinclair N, Zou X, et al. Epigenetic modifiers DNMT3A and BCOR are recurrently mutated in CYLD cutaneous syndrome. Nat Commun. 2019;10(1):4717.

XXII. Danilenko M, Stamp E, Stocken DD, Husain A, Zangarini M, Cranston A, et al. Targeting tropomyosin receptor kinase in cutaneous CYLD defective tumors with pegcantratinib: the TRAC randomized clinical trial. JAMA Dermatol. 2018;154(8):913-21.

XXIII. Nguyen K, Chen A, Shalabi MMK, Kelly B, Tolkachjov SN. Surgical outcomes of cylindrocarcinoma treated with Mohs micrographic surgery and excision: a systematic review. J Drugs Dermatol. 2025;24(5):444-6.

XXIV. Rodio M, Tettamanzi M, Trignano E, Rampazzo S, Serra PL, Grieco F, et al. Multidisciplinary management of cutaneous squamous cell carcinoma of the scalp: an algorithm for reconstruction and treatment. J Clin Med. 2024;13(6):1581.

XXV. Boschetti CE, Lo Giudice G, Staglianò S, Pollice A, Guida D, Magliulo R, et al. One-stage scalp reconstruction using single-layer dermal regeneration template and split-thickness skin graft: a case series. Oral Maxillofac Surg. 2024. doi:10.1007/s10006-024-01292-5.

XXVI. Kaushik S, Siegel D, Niermann K, Newman N. Whole scalp radiation therapy for recurrent benign cylindromas. Case Rep Dermatol. 2022;14(2):132-7.

XXVII. Poblete Gutiérrez P, Eggermann T, Höller D, Jugert FK, Beermann T, Grussendorf-Conen EI, et al. Phenotype diversity in familial cylindromatosis: a frameshift mutation in the tumor suppressor gene CYLD underlies different tumors of skin appendages. J Invest Dermatol. 2002;119(2):527-31.

Most read articles by the same author(s)